The European Commission has approved the oral targeted therapy pemigatinib (Pemazyre) for the treatment of…
View More Europe Approves Pemigatinib for Bile Duct CancerHome »
Home »
The European Commission has approved the oral targeted therapy pemigatinib (Pemazyre) for the treatment of…
View More Europe Approves Pemigatinib for Bile Duct Cancer